Annika T. Beck

Communicating unexpected pharmacogenomic results to biobank contributors: A focus group study.

R. Sharp, K. Meagher, Amal W. Cheema, 2020, Patient education and counseling.

Do patients with high versus low treatment and illness burden have different needs? A mixed-methods study of patients living on dialysis

Kathleen H. Pine, K. Boehmer, E. Behnken, 2021, PloS one.

Implementation of preemptive DNA sequence-based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study.

Joseph A. Sutton, Krishna R. Kalari, Sebastian M. Armasu, 2022, Genetics in medicine : official journal of the American College of Medical Genetics.

Integrating Genomic Screening into Primary Care: Provider Experiences Caring for Latino Patients at a Community-Based Health Center

I. Kullo, R. Sharp, N. Lindor, 2021, Journal of primary care & community health.

Experiences of Latino Participants Receiving Neutral Genomic Screening Results: A Qualitative Study

I. Kullo, R. Sharp, N. Lindor, 2021, Public Health Genomics.

Lay understandings of drug‐gene interactions: The right medication, the right dose, at the right time, but what are the right words?

R. Sharp, K. Meagher, Amal W. Cheema, 2021, Clinical and translational science.

Older Patients with Advanced Chronic Kidney Disease and Their Perspectives on Prognostic Information: a Qualitative Study

J. Tilburt, I. Hargraves, A. Kumbamu, 2022, Journal of General Internal Medicine.

“Who Doesn’t Like Receiving Good News?” Perspectives of Individuals Who Received Genomic Screening Results by Mail

I. Kullo, R. Sharp, Susan H Curtis, 2021, Journal of personalized medicine.

Patient reactions to receiving negative genomic screening results by mail

I. Kullo, R. Sharp, Joel E. Pacyna, 2020, Genetics in Medicine.

Patient reactions to receiving negative genomic screening results by mail

I. Kullo, R. Sharp, Joel E. Pacyna, 2020, Genetics in Medicine.